Pathophysiological vs biochemical ischaemia: a key to transition from reversible to irreversible damage
University of Ferrara & Cardiovascular Research Center, Salvatore Maugeri Foundation, Gussago, Brescia, Italy
* Correspondence: Prof. Roberto Ferrari, Chair of Cardiology, University of Ferrara, Corso Giovecca, 203, 44100 Ferrara, Italy.
Abstract
‘Myocardial ischaemia’ is defined as an imbalance between fractional uptake of oxygen and the rate of cellular oxidation in the heart. This condition may have several potential outcomes: (1) when ischaemia is brief, a transient post-ischaemic ventricular dysfunction occurs on reperfusion, a condition named ‘stunned myocardium’; (2) when it is prolonged and severe, irreversible damage occurs, with no recovery in contractile function upon reperfusion; (3) when ischaemia is less severe, but still prolonged, the myocytes may remain viable but exhibit depressed contractile function. Under this condition, named ‘hibernating myocardium’, the reperfusion is able to restore contractility.
During these different ischaemic conditions, many biochemical changes occur: initially they represent a defensive and protective reaction against ischaemia such as cellular acidosis and increase of inorganic phosphate levels that rapidly abolish the contractile activity. But with the prolongation of ischaemia and restoration of the coronary flow, alterations in ions and overall Ca2+ homeostasis occur, together with an oxidative stress mediated by oxygen free radicals, not adequately counteracted by the cellular antioxidant defences. The mitochondria are likely to play a central role in these events which leads to membrane damage and irreversible deterioration of contractile function. The issue of reperfusion injury, however, is not unanimously accepted. Many, but not all, cardiologists are of the opinion that some components of reperfusion may be detrimental and able to inflict injury over and above that attributable to ischaemia. This article defines the sequence of events occurring during the transition from angina to infarction.
Key Words: Angina • ischaemia • reperfusion • stunning • hibernation • myocardial infarction • metabolism
References
- Weber KT. Extracellular matrix remodelling in heart failure. A role for De Novo angiotensin II generation. Circulation. 1997;96:4065–4082
[Free Full Text] - Hearse DJ. Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res. 1994;28:1737–1744
- Opie LH. Reperfusion injury and its pharmacological modification. Circulation. 1989;80:1049–1062
[Abstract/Free Full Text] - Ferrari R, Hearse DJ. Reperfusion injury: does it exist and does it have clinical relevance? J Thromb Thrombol. 1997;4:25–34[CrossRef][Medline]
- Ferrari R, Cargnoni A, Bernocchi P, et al. Metabolic adaptation during a sequence of no-flow and low-flow ischaemia: a possible trigger for hibernation. Circulation. 1996;94:2587–2596
[Abstract/Free Full Text] - Braunwald E, Kloner RA. The stunned myocardium: Prolonged, post-ischaemic ventricular dysfunction. Circulation. 1982;66:1146–1149
[Abstract/Free Full Text] - Bolli R. Mechanism of myocardial "stunning". Circulation. 1990;82:723–738
[Abstract/Free Full Text] - Bolli R, Triana JF, Jeroudi MO. Prolonged impairment of coronary vasodilation after reversible ischaemia: Evidence for microvascular "stunning". Circ Res. 1990;67:332–343
[Abstract/Free Full Text] - Bolli R, Jeroudi MO, Patel B, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res. 1989;65:607–622
[Abstract/Free Full Text] - Ferrari R, Pedersini P, Bongrazio M, et al. Mitochondrial energy production and cation control in myocardial ischaemia and reperfusion. Basic Res Cardiol. 1993;88:495–512[CrossRef][ISI][Medline]
- Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol. 1973;5:395–407[CrossRef][ISI][Medline]
- Siegmund B, Zude R, Piper HM. Recovery of anoxicreoxygenated cardiomyocytes from severe Ca2+ overload. Am J Physiol. 1992;63:H1262–H1269
- Piper HM, Balser C, Ladilov YV, et al. The role of Na+/H+ exchange in ischaemia-reperfusion. Basic Res Cardiol. 1996;91:191–202[CrossRef][ISI][Medline]
- Ladilov YV, Siegmund B, Piper HM. Protection of the reoxygenated cardiomyocyte against hypercontracture by inhibition of Na+/H+ exchange. Am J Physiol. 1995;268:H1531–H1539
- Ruiz-Meana M, Garcia-Dorado D, Gonzales MA, Barrabes JA, Soler-Soler J. Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition. Cardiovasc Res. 1995;30:64–69[CrossRef][ISI][Medline]
- Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1983;72:V123–V135
- van Binsbergen XA, van Emous JG, Ferrari R, van Echteld CIA, Ruigrok TIC. Metabolic and functional consequences of successive no-flow and sustained low-flow ischaemia; a 31P MRS study a rat hearts. J Mol Cell Cardiol. 1996;28:2373–2381[CrossRef][ISI][Medline]
- Schulz R, Post H, Sakka S, Walbridge DR, Heusch G. Intraischaemic preconditioning. Increase tolerance to sustained low-flow ischaemia by a brief episode of no-flow ischaemia without intermittent reperfusion. Circ Res. 1995;76:942–950
[Abstract/Free Full Text] - Koning MMG, Simonis LAI, deZeeuw S, Nieukoop S, Post S, Verdouw PD. Ischaemic preconditioning by partial occlusion with out intermittent reperfusion. Cardiovasc Res. 1991;28:1146–1151
- Schulz R, Heusch G. Ischaemic preconditioning and myocardial hibernation: is there a common mechanism? Basic Res Cardiol. 1996;91:50–52[ISI][Medline]
- Heusch G, Ferrari R, Hearse DJ, Ruigrok TIC, Schulz R. Myocardial hybernation-questions and controversies. Cardiovase Res. 1997;36:301–309
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||